Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.
Benedikt Silvester HoferLukas BurghartEmina HalilbasicBenedikt SimbrunnerOleksandr PetrenkoMattias MandorferAlbert Friedrich StättermayerMichael TraunerThomas ReibergerPublished in: Alimentary pharmacology & therapeutics (2024)
Patients with PBC and decompensated cirrhosis may achieve hepatic recompensation under UDCA therapy. However, since liver-related complications still occur after recompensation, patients should remain under close follow-up.
Keyphrases
- ejection fraction
- heart failure
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- stem cells
- risk factors
- patient reported outcomes
- liver failure
- bone marrow
- mesenchymal stem cells
- hepatitis b virus
- atrial fibrillation
- patient reported
- cell therapy
- replacement therapy